Dexcom (DXCM) Total Non-Current Liabilities (2016 - 2025)
Dexcom (DXCM) has disclosed Total Non-Current Liabilities for 16 consecutive years, with $3.5 billion as the latest value for Q4 2025.
- Quarterly Total Non-Current Liabilities fell 18.36% to $3.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.5 billion through Dec 2025, down 18.36% year-over-year, with the annual reading at $3.5 billion for FY2025, 18.36% down from the prior year.
- Total Non-Current Liabilities for Q4 2025 was $3.5 billion at Dexcom, down from $4.6 billion in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $4.6 billion in Q3 2025, with the low at $2.4 billion in Q1 2021.
- Average Total Non-Current Liabilities over 5 years is $3.6 billion, with a median of $3.8 billion recorded in 2023.
- The sharpest move saw Total Non-Current Liabilities soared 61.09% in 2021, then fell 18.36% in 2025.
- Over 5 years, Total Non-Current Liabilities stood at $2.8 billion in 2021, then grew by 11.79% to $3.1 billion in 2022, then increased by 29.98% to $4.1 billion in 2023, then increased by 4.02% to $4.2 billion in 2024, then fell by 18.36% to $3.5 billion in 2025.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $3.5 billion, $4.6 billion, and $4.6 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.